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Abstract Clone 9 liver cells incubated under aerobic conditions
with the proteasome inhibitors lactacystin, clastro lactacystin
L-lactone, and tri-leucine vinyl sulfone, in the absence of an
obvious oxidative challenge, underwent oxidative protein modi-
¢cations, such as loss of solubility, formation of aggregates
(predominantly by disul¢de bridges), and increased carbonyl
formation, similar to those seen with hydrogen peroxide treat-
ment. These alterations were accompanied by modi¢cation of
cell morphology and loss of cell viability. Remarkably, almost
all of these modi¢cations were prevented when cell incubation
with proteasome inhibitors was performed under a 3% oxygen
atmosphere instead of the 21% oxygen routinely used in cell
culture experiments. Our results suggest an oxygen-dependent
mechanism for the protein oxidation, protein aggregation, cel-
lular dysfunction, and apoptosis induced by proteasome inhibi-
tors.
( 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Inhibition of proteasome activity has been associated with
apoptotic responses in various cell types [1,2]. It is known that
the induction of apoptosis by proteasome inhibition occurs
following an initial accumulation of short-lived proteins
such as p53, p27, and pro-apoptotic Bcl-2 family members
[2]. The mechanism by which apoptosis is triggered by de-
creased proteasomal activity, however, remains speculative.
We have reported that proteasome inhibition in rat liver ep-
ithelial cells modi¢es glutathione metabolism, and causes in-
tense protein S-glutathionylation [3]. Thus, alteration of cel-
lular redox status and oxidative protein modi¢cations should
also be considered during proteasome inhibition. Our goal in
the present study was to explore oxidative alterations to the
pool of intracellular proteins after cell incubation with pro-
teasome inhibitors, since accumulation of modi¢ed proteins
may disrupt cellular function either by loss of catalytic and
structural integrity, or by disruption of regulatory pathways
[4].
We selected rat liver epithelial cells, and lactacystin, its de-
rivative clastro lactacystin L-lactone and tri-leucine vinyl sul-
fone (NLVS) as proteasome inhibitors. Our criteria for the
selection of the proteasome inhibitors included their ability
to act as irreversible inhibitors of the proteasome [5], their
previous utilization in functional studies of proteasomal activ-
ity, and their di¡erent structures. Clastro lactacystin L-lac-
tone, the active product of lactacystin hydrolysis, is consid-
ered a more powerful inhibitor than is lactacystin [6,7].
NLVS, di¡erent from other structurally related proteasome
inhibitors, was the ¢rst peptide found to exert irreversible
and selective proteasome inhibition [8,9]. To compare damage
promoted by proteasome inhibitors with that induced by oxi-
dative stress, we used cell treatment with H2O2 as a common
and biologically relevant form of oxidative challenge.
2. Materials and methods
2.1. Materials
Lactacystin, clastro lactacystin L-lactone, and NLVS were pur-
chased from Calbiochem. The £uorogenic substrate succinyl-Leu-
Leu-Val-Tyr-MCA (s-LLVY-MCA) was purchased from Sigma.
[35S]Methionine/cysteine and NaB[3H4] were purchased from NEN1
Life Science Products. Cell culture media, fetal bovine serum, and
phosphate-bu¡ered saline solution were purchased from Gibco. Brad-
ford protein assay reagents were purchased from Bio-Rad.
2.2. Cells and cell culture
Clone 9 liver cells (normal rat liver epithelium) were obtained from
American Type Culture Collection (ATCC CRL 1439). The cells were
cultured in Ham’s F-12K medium, supplemented with 10% fetal bo-
vine serum. Samples of 2.5U106 cells were plated and grown for
4 days before treatment. Cells were grown in a model 3130 Forma
Scienti¢c incubator with 5% carbon dioxide, and either 21% or 3%
oxygen; all gases were automatically regulated. All media were pre-
equilibrated with the appropriate gas mixtures before application to
cells.
2.3. Incubation of clone 9 liver cells with proteasome inhibitors and
treatment with hydrogen peroxide
On the fourth day after seeding, cells were incubated with protea-
some inhibitors (1^10 WM with 1U105 cells/cm2) in culture medium,
or treated with H2O2 (200^400 WM with 3U106 cells/cm2) for 30 min
at 37‡C in phosphate-bu¡ered saline (pH 7.4). After H2O2 treatment,
cells were washed three times and incubated in culture medium for
24 h.
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2.4. Cellular viability
Variation in the number of viable cells following incubation with
proteasome inhibitors, and after treatment with hydrogen peroxide,
was determined with the CellTiter 960 AQueous Non-Radioactive Cell
Proliferation Assay (Promega), according to the manufacturer’s pro-
tocol. The cells were seeded at a density of 10 000/well/100 Wl (96-well
plate, Corning) and incubated in the presence of proteasome inhib-
itors or treated with H2O2 4 h after plating. Cell viability was deter-
mined every 4 h.
2.5. Proteolysis determination
Proteolysis ratios were determined in cell extracts (100^200 Wg pro-
tein) by hydrolysis of the £uorogenic substrate s-LLVY-MCA as pre-
viously described [3].
2.6. [35S]Methionine/cysteine protein labeling
Cells were incubated with [35S]methionine/cysteine, in methionine/
cysteine-free minimal essential Eagle’s medium, for 16 h at 37‡C.
After incubation, the labeling mixture was removed and the cells
were washed three times with phosphate-bu¡ered saline. This was
followed by a 2 h incubation in the methionine/cysteine-free medium,
and a further washing procedure.
2.7. Preparation of cell extracts and protein samples
Cell extracts were prepared by sonication of cell pellets. Detergent-
soluble cell proteins were obtained by resuspension of cell pellets in a
detergent-bu¡ered solution consisting of: 1% Triton X-100, 0.5% so-
dium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS), in
10 mM Tris^HCl/1 mM EDTA, pH 8 [10]. After cell lysis (15 min
at 4‡C followed by vigorous stirring), samples were centrifuged at
13 000Ug for 10 min. The supernatant contained detergent-soluble
proteins, whereas the pellet contained detergent-insoluble proteins.
Quanti¢cation of the detergent-insoluble protein fraction was
achieved using a [35S]methionine/cysteine protein labeling procedure
before treatments. The detergent-insoluble pellet, after three washes,
was dissolved in 0.1 N NaOH and subjected to scintillation counting.
Detergent-insoluble proteins were solubilized, when speci¢ed, in a
detergent-bu¡ered solution consisting of: 4% Triton X-100, 2% so-
dium deoxycholate, and 0.4% SDS, in 10 mM Tris^HCl/1 mM EDTA
pH 8 [10]. Protein concentration was determined using Bradford re-
agents.
2.8. Polyacrylamide gel electrophoresis (PAGE)
Protein preparations, 35S-labeled or unlabeled proteins, were elec-
trophoresed by SDS^PAGE according to Bollag et al. [11].
2.9. Determination of protein carbonyl derivatives
Protein carbonyls were quanti¢ed as described in [12] by 3H-label-
ing carbonyl groups during reduction with NaB[3H4]. A Western blot-
ting immunoassay was performed as described in [13]. The antibodies
were: rabbit anti-dinitrophenyl IgG (monoclonal, Sigma) and horse-
radish peroxidase-conjugated A⁄niPure goat anti-rabbit IgG (Jack-
son ImmunoResearch). Blotting identi¢cation was performed with the
chemiluminescence kit ECL Western Blotting Detection (Amersham).
3. Results
We initially undertook this investigation to explore the hy-
pothesis that the proteasome plays an important role in over-
all cell defenses against oxidants by catalyzing the selective
removal of oxidatively modi¢ed proteins [14^19]. We started
by testing for an intracellular accumulation of oxidatively
modi¢ed proteins, after exposure of cells to hydrogen perox-
ide during inhibition of proteasomal activity. During the ex-
periments, however, we observed that cells incubated in the
presence of proteasome inhibitors alone accumulated oxidized
proteins to a similar extent as did cells solely pretreated with
C
Fig. 1. Formation of detergent-insoluble oxidized protein aggregates
in clone 9 liver cells treated with proteasome inhibitors or hydrogen
peroxide. A cellular protein pellet was obtained as described in Sec-
tion 2. A: Cells (at 1U105 cells/cm2) were incubated for 24 h with
proteasome inhibitors at the concentrations indicated. B: Treatment
with H2O2 was performed for 30 min (at 3U106 cells/cm2) followed
by a further 24 h incubation. C: The cells (at 1U105 cells/cm2)
were maintained for 24 h under either a 3% or a 21% oxygen atmo-
sphere, in the presence or absence of 1 WM lactacystin. In A the
formation of protein aggregates after treatment with proteasome in-
hibitors is expressed as a percentage of 35S counts in the aggregates
compared to 35S counts per mg of total cell protein. B shows a
comparison of lactacystin and H2O2 as inducers of protein aggre-
gates. C shows the production of protein aggregates as a function
of ambient oxygen concentration. In B and C 35S counts of deter-
gent-insoluble pellets were compared to control samples set as 1.00.
Results shown are meanVS.D. of four independent experiments.
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hydrogen peroxide. This observation motivated both a pre-
vious publication [3] and the present experiments.
In this study proteolysis was tested in cell extracts, obtained
after cell incubation with proteasome inhibitors, by hydrolysis
of the £uorogenic substrate s-LLVY-MCA. The e¡ects of the
inhibitors were dose-dependent, but were quite similar for all
three agents tested. In cells incubated for 24 h with 1^5 WM
lactacystin, clastro lactacystin L-lactone, or NLVS we found
40V 10% to 90V 5% inhibition of proteolysis, in comparison
with control samples.
Cell viability followed over a 2^24 h period was dependent
on the concentration of proteasome inhibitor, or H2O2 uti-
lized. After 24 h, cell viability was 30% with 1 WM lactacystin,
28% with 5 WM NLVS, and 59% with 400 WM H2O2, of
control cell values. However, contrary to cells incubated
with proteasome inhibitors, the growth of H2O2-treated cells
was almost completely recovered 48 h later. Cells treated with
both a proteasome inhibitor and H2O2 failed to grow, and did
not recover at any point.
Since oxidatively modi¢ed proteins can form large aggre-
gates due to covalent cross-linking and consequent loss of
solubility [10,17,20^27], we looked for the formation of in-
soluble aggregates after treatment with H2O2 and incubation
with proteasome inhibitors, by measuring the formation of
detergent-insoluble protein fractions. Newly synthesized cell
proteins were metabolically labeled with [35S]methionine/cys-
teine before cell treatment, and the total protein content of
treated cells was recovered after 24 h in a detergent-bu¡ered
solution. Labeled protein that could not be solubilized in de-
tergent was recovered as the detergent-insoluble protein pellet,
after centrifugation (see Section 2). The amount of material in
the detergent-insoluble protein pellet was increased at least
13-fold in samples from cells treated with 1 WM NLVS com-
pared to the insoluble protein pool of control cells, and as
much as a 60-fold increase was seen in samples obtained from
cells incubated with 5 WM lactacystin (Fig. 1A). The loss of
protein solubility was dependent on the dose of proteasome
inhibitor and did not di¡er signi¢cantly between samples ob-
tained from cells incubated with any of the three inhibitors
tested (Fig. 1A). Loss of protein solubility after cell incuba-
tion with 5 WM lactacystin was similar to that obtained after
treatment with 200 or 400 WM hydrogen peroxide (Fig. 1B).
The loss of protein solubility after cell incubation with pro-
teasome inhibitors was a relatively early event, since the for-
mation of a detergent-insoluble protein pellet was observed
after only 4 h of incubation in the presence of 2.5 WM lacta-
cystin: 30% higher than control values.
Next we incubated cells in the presence of 1 WM lactacystin,
either under an atmosphere of only 3% oxygen, or in the
regular 21% oxygen atmosphere (room air) routinely used
by almost all investigators for cell culture studies. After 24 h
of incubation the cells were assayed for loss of protein solu-
bility. We found that at 3% O2 the lactacystin-induced de-
crease in protein solubility was essentially blocked in compar-
ison with cells grown under the usual 21% O2 atmosphere
(Fig. 1C). This result indicates that formation of an insoluble
protein pool, induced by proteasome inhibitors, is dependent
on oxygen.
Detergent-insoluble pellets obtained from cells 24 h after
treatment with 400 WM H2O2 or with 2.5 WM lactacystin
were solubilized and protein carbonyl derivatives were mea-
sured by reaction with NaB[3H4]. The amount of carbonyl
protein derivatives formed was relatively similar in samples
from H2O2-treated cells (480V 15 3H countsU103/mg protein)
and lactacystin-treated cells (400V 21 3H countsU103/mg pro-
tein) but both were ¢ve- to six-fold higher than in extracts
from control cells (83 V 14 3H countsU103/mg protein). In
actuality our control values are probably an overestimation,
since control cells subjected to the same procedure did not
yield a large enough detergent-insoluble protein pellet to be
assayed, hence carbonyl derivatives were measured in total
cell protein.
Fig. 2. Disul¢de protein cross-linking in clone 9 liver cells treated with lactacystin or hydrogen peroxide. Cell proteins were metabolically la-
beled with [35S]methionine/cysteine and incubated for 24 h in the presence of proteasome inhibitors, or were exposed to H2O2 treatment (as in
Fig. 1). Cellular detergent-soluble protein samples were applied to SDS^PAGE (50 Wg/well). Stacking and resolving gels were 3% and 5% poly-
acrylamide, respectively. After Coomassie blue staining, the gels were dried and divided in vertical slices of 0.4 cm width. The slices were cut in
12 equal pieces (indicated as ‘Gel bands’ on the x-axis) and maintained overnight in liquid scintillation cocktail before counting. Results are ex-
pressed as a percentage 35S counts per band compared to 35S counts/mg total cell protein. The results shown are meanVS.D. of four indepen-
dent experiments. Inset: Values obtained from samples following reduction with 0.04% L-mercaptoethanol.
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We next looked for aggregates in the detergent-soluble pro-
tein fraction on SDS^PAGE, after cell incubation under sim-
ilar experimental conditions (Fig. 2). Both the formation of
high molecular weight protein bands (220^330 kDa) and their
attenuation after chemical reduction with 0.04% L-mercapto-
ethanol was observed (Fig. 2). Greatest protein aggregation
was found in the high molecular weight range (220^330 kDa,
bands 1^4) in samples from cells incubated with 5 WM lacta-
cystin (5.4% of total 35S counts) or treated with 400 WM H2O2
(1.2% of total 35S counts). In contrast, less than 0.7% of total
protein was found in same gel bands from control samples.
All high molecular weight protein bands (220^330 kDa) were
profoundly attenuated when samples were reduced with
L-mercaptoethanol (inset in Fig. 2). Protein concentration in
the high molecular weight bands of lactacystin- and H2O2-
treated samples after reduction with L-mercaptoethanol was
close to that found in control samples subjected to the same
procedure, ca. 0.6% of total protein. From these results one
may infer that inter-protein disul¢de bond formation was a
major cause for the appearance of detergent-soluble protein
aggregates. Even upon mild proteasome inhibition (40% inhi-
bition after 24 h of cell incubation in the presence of 1 WM
lactacystin) we observed formation of protein aggregates that
could be partially dispersed by chemical reduction with L-mer-
captoethanol (result not shown).
To further explore whether protein modi¢cations are caused
by oxidative mechanisms, protein carbonyl derivatives [4]
were determined in samples from cells incubated with protea-
some inhibitors. Immunoblotting of protein carbonyl groups
evaluated in detergent-soluble protein samples from cells in-
cubated with 1, 2.5, and 5 WM lactacystin or 2.5 and 5 WM
NLVS showed increased carbonyl formation at all inhibitor
concentrations (upper panel of Fig. 3). When averaged over
three independent experiments, carbonyl formation was seen
Fig. 3. Protein carbonyl formation induced by proteasome inhibitors
in clone 9 liver cells. Cells were lysed in a detergent-bu¡ered solu-
tion 24 h after incubation (as in Fig. 1) with inhibitors at the indi-
cated concentrations. After derivatization with dinitrophenylhydra-
zine, the lysates (5 Wg protein/well) were applied to 8% SDS^PAGE.
The carbonyl immunoassay was performed according to Shacter et
al. [13]. The blot shown in the upper panel is representative of all
experiments. In the lower panel gels from three independent experi-
ments were scanned, and the optical density of each experimental
sample was expressed relative to control values, arbitrarily set as
1.00. Each histogram represents meanVS.D. of three independent
experiments. Signi¢cant di¡erences (*P6 0.001 compared to control
samples) are indicated.
Fig. 4. Oxygen dependence of clone 9 cell death induced by proteasome inhibitors. Representative cell pictures of a light microscopic view
(20U magni¢cation) (Nikon Diaphot) 24 h after incubation (as in Fig. 1) with lactacystin or NLVS at the concentrations indicated. The top
three panels all show results with cells grown under a 21% O2 atmosphere. In contrast, the bottom three panels show cells grown under an at-
mosphere of only 3% O2. Pictures were taken from three or four random ¢elds in the culture plates.
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to increase by 60^80% after 24 h of cell incubation in the
presence of 2.5^5.0 WM lactacystin or NLVS (Fig. 3, lower
panel).
Cell morphology, visualized by optical microscopy, during
cell incubation under a 21% oxygen atmosphere with 5 WM
lactacystin or NLVS revealed profound modi¢cations (Fig. 4,
top three panels). Many cells can be seen to have detached
from the surface (arrows in Fig. 4), or to have become en-
larged, or ruptured (and clearly dead). When cells were incu-
bated under a 3% oxygen atmosphere, however, these e¡ects
were almost completely blocked (Fig. 4, bottom three panels).
These data, in agreement with other results shown above,
indicate that oxidative processes underlie the protein modi¢-
cations and cell death we now report during proteasome in-
hibition in mammalian cells.
4. Discussion
Proteasome inhibitors have been widely used in functional
studies of proteasome-dependent protein turnover, and are
considered important tools in the study of apoptosis. During
the ¢rst semester of 2002, 46 articles were published on this
issue, according to a search performed with Pubmed Tutorial
system (US National Library of Medicine). Moreover, there is
an important body of citations suggesting the possible utility
of proteasome inhibitors in cancer therapy, based mainly on
their pro-apoptotic activity (42 citations according to the
same source and period of time). Our results show that during
proteasome inhibition, without an obvious oxidative stress,
the intracellular protein pool underwent modi¢cations that
resemble those observed after H2O2 treatment (utilized here
for comparative purposes). Hydrogen peroxide levels utilized
in the assays described above (200^400 WM H2O2 with 3U105
cells/cm2 ; equivalent to a ¢nal concentration range of 66^133
WM) are related to mild oxidative damage when used in cul-
tured cells [15^17]. The modi¢cations reported here include
complete insolubility even in detergents, aggregation even in
detergents, carbonyl group formation, sulfhydryl oxidation,
changes in cell morphology, and cell death. All of these mod-
i¢cations may be taken to suggest an oxidative mechanism
underlying the e¡ects of proteasome inhibition.
An increased pool of substrates for oxidation, since protein
turnover is decreased when proteasome activity is inhibited,
could be an explanation for increased oxidative protein dam-
age during proteasome inhibition. However, 24 h protein
turnover accounts for the degradation of no more than 5%
of intracellular protein. Recently we reported intense protein
S-glutathionylation in extracts of cells incubated with the
same proteasome inhibitors utilized in the present study [3].
Protein S-glutathionylation was accompanied by increased
levels of total glutathione, and of mRNA encoding the rate-
limiting enzyme glutamate cysteine ligase (EC 6.3.2.2, for-
merly called Q-glutamylcysteine synthetase) in reduced gluta-
thione (GSH) biosynthesis. Since in vitro experiments revealed
that the 20S proteasome extracted from mammalian cells was
35S-glutathionylated after incubation with the inhibitors [3],
we concluded that proteasome inhibitors promote in vivo
structural alterations in the 20S proteasome core, allowing
its S-glutathionylation, and thereby altering intracellular
GSH availability because of GSH diversion to protein S-glu-
tathionylation. Increased GSH consumption may start by 20S
proteasome core S-glutathionylation, thus decreasing intracel-
lular reductive capacity, and consequently, increasing the size
of the intracellular pool of oxidized proteins. We suggest that
this mechanism may, at least partly, explain the results shown
here, since intracellular protein damage during cell incubation
with proteasome inhibitors is widespread and is similar to the
damage observed during oxidative stress. Our results may also
help to explain reports in the literature indicating that protea-
some inhibition promotes oxidative damage to macromole-
cules such as proteins, lipids, and DNA [28] as well as alter-
ations in glutathione metabolism [29].
Further experiments will be needed in order to truly under-
stand the mechanisms of protein damage during proteasome
inhibition. Of potentially greatest signi¢cance, however, is the
new ¢nding that the apoptotic cell death induced by protea-
some inhibitors is largely dependent upon oxygen concentra-
tion. This result strongly suggests that proteasome inhibition
causes apoptosis via increased oxidative stress. We suggest
that the cellular oxidative protein damage here reported
underlies the apoptotic phenomenon during proteasome inhi-
bition. If this hypothesis can be veri¢ed it will have serious
implications for the use of proteasome inhibitors in cancer
therapy, as well as other medical applications.
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